Cancer Research & Treatment

Cancer Research & Treatment A peer-reviewed open access publication of the Korean Cancer Association. Indexed by SCIE, Medline,

Diagnostic Challenges and Clinical Implications of Microsatellite Instability/Mismatch Repair Deficiency in Solid Tumors...
26/03/2026

Diagnostic Challenges and Clinical Implications of Microsatellite Instability/Mismatch Repair Deficiency in Solid Tumors
🌷https://doi.org/10.4143/crt.2025.1161
Cancer Res Treat 2026;58(1). Yoonjin Kwak

Exploring Oncologists’ Perspectives on the Early Integration of Specialty Palliative Care in Korea: Challenges, Needs, a...
25/03/2026

Exploring Oncologists’ Perspectives on the Early Integration of Specialty Palliative Care in Korea: Challenges, Needs, and Clinical Implications
🌷https://doi.org/10.4143/crt.2025.158
Cancer Res Treat 2026;58(1). Shin Hye Yoo

Pilot Study for Feasibility of Onco-Geriatric Intervention Model in Older Patients with Cancer in a Tertiary Academic Ho...
23/03/2026

Pilot Study for Feasibility of Onco-Geriatric Intervention Model in Older Patients with Cancer in a Tertiary Academic Hospital
🌷https://doi.org/10.4143/crt.2025.079
Cancer Res Treat 2026;58(1). Jin Won Kim

Real-World Experience of Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Multiple Myeloma R...
20/03/2026

Real-World Experience of Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Multiple Myeloma Relapsed/Refractory to Bortezomib and Lenalidomide
🌷https://doi.org/10.4143/crt.2025.418
Cancer Res Treat 2026;58(1). Cheongin Yang

Validating the Korean Geriatric Assessment Tool in Elderly Multiple Myeloma Patients: A Multicenter Study🌷https://doi.or...
18/03/2026

Validating the Korean Geriatric Assessment Tool in Elderly Multiple Myeloma Patients: A Multicenter Study
🌷https://doi.org/10.4143/crt.2025.066
Cancer Res Treat 2026;58(1). Ji Yun Lee

A Multicenter Phase II Study of Modified FOLFIRINOX for First-Line Treatment for Advanced Urachal Cancer (ULTIMA; KCSG G...
16/03/2026

A Multicenter Phase II Study of Modified FOLFIRINOX for First-Line Treatment for Advanced Urachal Cancer (ULTIMA; KCSG GU20-03)
🌷https://doi.org/10.4143/crt.2024.1231
Cancer Res Treat 2026;58(1). Inkeun Park

Combined Transarterial Chemoembolization and External Beam Radiotherapy for Identifying Surgical Candidates for Hepatoce...
12/03/2026

Combined Transarterial Chemoembolization and External Beam Radiotherapy for Identifying Surgical Candidates for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score–Weighted Analysis
🌷https://doi.org/10.4143/crt.2025.076
Cancer Res Treat 2026;58(1). Sumin Lee

Survival Rates of Patients with Gastric Cancer According to Age and S*x: A Large-Scale Study Using Data from 14,739 Pati...
10/03/2026

Survival Rates of Patients with Gastric Cancer According to Age and S*x: A Large-Scale Study Using Data from 14,739 Patients
🌷https://doi.org/10.4143/crt.2025.149
Cancer Res Treat 2026;58(1). Yonghoon Choi
, *x,

The Impact of Obesity on Treatment Outcomes in Patients with Hormone Receptor–Positive HER2-Negative Metastatic Breast C...
09/03/2026

The Impact of Obesity on Treatment Outcomes in Patients with Hormone Receptor–Positive HER2-Negative Metastatic Breast Cancer Receiving CDK 4/6 Inhibitors
🌷https://doi.org/10.4143/crt.2025.110
Cancer Res Treat 2026;58(1). Yoo Bin Jung

Spatial Transcriptomic Landscape of Brain Metastases from Triple-Negative Breast Cancer: Comparison of Primary Tumor and...
05/03/2026

Spatial Transcriptomic Landscape of Brain Metastases from Triple-Negative Breast Cancer: Comparison of Primary Tumor and Brain Metastases Using Spatial Analysis
🌷https://doi.org/10.4143/crt.2025.033
Cancer Res Treat 2026;58(1). Jihwan Yoo

The Role of Circulating Tumor Cell as a Promising Biomarker in the Evaluation of Pulmonary Nodules: A Prospective Study🌷...
04/03/2026

The Role of Circulating Tumor Cell as a Promising Biomarker in the Evaluation of Pulmonary Nodules: A Prospective Study
🌷https://doi.org/10.4143/crt.2024.841
Cancer Res Treat 2026;58(1). Shijie Wang

Cost-Effectiveness Analysis of Daratumumab Monotherapy and Subsequent Therapies in Heavily Treated Relapsed/Refractory M...
25/02/2026

Cost-Effectiveness Analysis of Daratumumab Monotherapy and Subsequent Therapies in Heavily Treated Relapsed/Refractory Multiple Myeloma: A Feasible Methodology using a Korean Nationwide Population Cohort
🌷https://doi.org/10.4143/crt.2025.046
Cancer Res Treat 2026;58(1). Sung-Soo Park

Address

Jongno District
03186

Alerts

Be the first to know and let us send you an email when Cancer Research & Treatment posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cancer Research & Treatment:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram